Post by
greenpasture on Dec 15, 2015 7:53pm
Nasdaq Biotechnology Index inclusion Dec 21
Please re-read today's news. I would hate to be short cxr going into 2016. All I can say is CREDIBILITY.
Comment by
slightfan1 on Dec 15, 2015 9:13pm
posters do not seem to realize that being included in the index is a double edged sword.
Comment by
slightfan1 on Dec 16, 2015 8:59am
it is prone to the ups and downs of the index; a 2 way street.
Comment by
slightfan1 on Dec 16, 2015 9:23am
I hear you and I understand. But now we are more closely correlated to the index even if we do not have "the fleas" that others might. \Be that as it may, it is just a fact. Good sometimes; bad sometimes. re: your faxed drink; lasted me 2 seconds but it was a quality drink. Thank you.
Comment by
sunshine7 on Dec 16, 2015 9:52am
While the addition to the bio index may provide some 'noise' to SP, I can only believe that exposure to international institutional funds will be a positive as CXR seeks out its true intrinsic value. It will be less prone to market manipulation I think. Note that VRX is not included in the index.
Comment by
adamchess on Dec 16, 2015 12:08am
Initially, being part of the Index should be very positive because all the healthcare funds that include biotech stocks will have to purchase CXR in quantity to meet their percentages. This includes many ETFs that are huge in the amount of many billion dollars. It would be interesting to track the effect on the stocks that were recently included in said index.
Comment by
FingBucko on Dec 15, 2015 10:48pm
Sorry if this has already been posted. Hope the link works.. been a while since ive linked somethign on Stockhouse.
Concordia Pays Down Debt
Cheers!